InfuSystems Holdings, Inc. Common Stock (INFU)
4.7600
-0.2700 (-5.37%)
NYSE · Last Trade: Apr 4th, 9:48 AM EDT
Detailed Quote
| Previous Close | 5.030 |
|---|---|
| Open | 4.760 |
| Bid | 4.760 |
| Ask | 4.930 |
| Day's Range | 4.760 - 4.930 |
| 52 Week Range | 4.843 - 9.970 |
| Volume | 7,817 |
| Market Cap | 97.91M |
| PE Ratio (TTM) | 47.60 |
| EPS (TTM) | 0.1 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 149,796 |
Chart
About InfuSystems Holdings, Inc. Common Stock (INFU)
InfuSystem Holdings is a leading provider of infusion therapy services and equipment, primarily focused on supporting healthcare providers and patients with specialized medical needs. The company offers a range of products, including infusion pumps, related accessories, and services that help manage pain, deliver chemotherapy, and facilitate other types of infusion therapy. InfuSystem is committed to enhancing patient care through its innovative solutions and personalized support, catering to both home healthcare settings and hospital environments. Their expertise ensures that patients receive the necessary treatment while maintaining the highest standards of safety and reliability. Read More
News & Press Releases
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced that Richard DiIorio will be stepping down as the Company’s Chief Executive Officer, effective May 19, 2025. Concurrently, the Company announced that Carrie Lachance, the Company’s President and Chief Operating Officer, and a member of the Company’s board of directors, will assume the role of Chief Executive Officer effective May 19, 2025. Following such date, Mr. DiIorio has agreed to remain available as an advisor to Ms. Lachance, in support of the transition.
By InfuSystem Holdings, Inc. · Via Business Wire · April 1, 2025
InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2024.
By InfuSystem Holdings, Inc. · Via Business Wire · March 4, 2025
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025, before the market opens.
By InfuSystem Holdings, Inc. · Via Business Wire · February 25, 2025
NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December 4-5, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Via ACCESSWIRE · December 3, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, Chief Executive Officer, Barry Steele, Chief Financial Officer, and Carrie Lachance, President and Chief Operating Officer, will present at the Sidoti Small Cap Virtual Investor Conference at 10:00 a.m. ET on Wednesday, December 4, 2024.
By InfuSystem Holdings, Inc. · Via Business Wire · November 22, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today the appointment of Ronald Hundzinski, as an independent director to InfuSystem’s Board of Directors, effective November 12, 2024. Mr. Hundzinski will serve as a director until he stands for election at InfuSystem’s next Annual Shareholders meeting in May 2025.
By InfuSystem Holdings, Inc. · Via Business Wire · November 18, 2024
InfuSystem Holdings, Inc. (NYSE American:INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2024.
By InfuSystem Holdings, Inc. · Via Business Wire · November 7, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2024 financial results on Thursday, November 7, 2024, before the market opens.
By InfuSystem Holdings, Inc. · Via Business Wire · October 31, 2024
Two medical device companies with strong buy ratings are positioned for growth in the growing healthcare devices market.
Via MarketBeat · October 10, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, Chief Executive Officer, Carrie Lachance, President and Chief Operating Officer and Barry Steele, Chief Financial Officer will participate in the Lytham Partners Fall 2024 Investor Conference on Tuesday, October 1, 2024.
By InfuSystem Holdings, Inc. · Via Business Wire · September 27, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, and its joint venture partner Sanara MedTech Inc. (“Sanara”), announced today the execution of an exclusive United States distribution agreement with ChemoMouthpiece, LLC (“ChemoMouthpiece”).
By InfuSystem Holdings, Inc. · Via Business Wire · September 11, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, Chief Executive Officer and Barry Steele, Chief Financial Officer will participate in Lake Street Capital Markets’ 8th Annual Best Ideas Growth (BIG8) Conference on Thursday, September 12, 2024. The conference is being held at The Yale Club in New York City.
By InfuSystem Holdings, Inc. · Via Business Wire · September 4, 2024
InfuSystem Holdings, Inc. (NYSE American:INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2024.
By InfuSystem Holdings, Inc. · Via Business Wire · August 8, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today a three-year distribution agreement with Smith+Nephew for its innovative negative pressure wound therapy (“NPWT”) system and supplies.
By InfuSystem Holdings, Inc. · Via Business Wire · August 6, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens.
By InfuSystem Holdings, Inc. · Via Business Wire · August 2, 2024
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Via ACCESSWIRE · June 11, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, Chief Executive Officer, Barry Steele, Chief Financial Officer, and Carrie Lachance, President and Chief Operating Officer, will present at the Sidoti Small Cap Virtual Investor Conference at 8:30 a.m. ET on Wednesday, June 12, 2024.
By InfuSystem Holdings, Inc. · Via Business Wire · June 4, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company’s Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $20 million of the Company’s outstanding common stock through June 30, 2026. The program supersedes the previous authorization which was set to expire on June 30, 2024. Under the previous authorization, the Company repurchased approximately 550 thousand shares of stock for approximately $6.2 million. Repurchases will be made through open market purchases, private transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934 (the “Exchange Act”).
By InfuSystem Holdings, Inc. · Via Business Wire · May 20, 2024
INFU stock results show that InfuSystems Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2024.
By InfuSystem Holdings, Inc. · Via Business Wire · May 9, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2024 financial results on Thursday, May 9, 2024, before the market opens.
By InfuSystem Holdings, Inc. · Via Business Wire · May 2, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company has received notice from the NYSE Regulation (the "Notice") stating that the Company is not in compliance with the continued listing standards of the NYSE American LLC (the "Exchange") under the timely filing criteria included in Section 1007 of the NYSE American Company Guide (the "Company Guide") because the Company failed to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the "Delinquent Report"), which was due to be filed with the Securities and Exchange Commission (the "SEC") no later than April 1, 2024 (the "Filing Delinquency").
By InfuSystem Holdings, Inc. · Via Business Wire · April 3, 2024
These beaten-down growth stocks seem primed for a comeback, with the potential to deliver substantial returns.
Via InvestorPlace · March 26, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024